文献速递小儿眼科与斜弱视

肉毒毒素治疗婴儿性内斜视:一项系统评价与Meta分析

The Use of Botulinum Toxin to Treat Infantile Esotropia: A Systematic Review With Meta-Analysis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

该系统评价纳入9项研究,评估肉毒毒素注射治疗婴儿性内斜视的疗效与并发症。合并成功率为76%(95%CI:61%-89%),异质性I²=94.25%(P<0.001);合并连续性外斜视率为1%(95%CI:0%-2%),上睑下垂率为27%(95%CI:21%-33%),垂直偏斜率为12%(95%CI:4%-22%);注射后偏斜度平均变化为-30.7(95%CI:-37.7,-23.8),显示眼位显著改善。作者认为肉毒毒素注射内直肌是安全的,可作为先天性内斜视斜视手术的有价值替代方案,尤其适用于中度偏斜。

要点

  • 合并成功率76%(95%CI:61%-89%),异质性高(I²=94.25%,P<0.001)。
  • 合并连续性外斜视率1%(95%CI:0%-2%),上睑下垂率27%(95%CI:21%-33%),垂直偏斜率12%(95%CI:4%-22%)。
  • 偏斜度平均变化-30.7(95%CI:-37.7,-23.8),显示眼位显著改善。

核心结论

  • 作者认为肉毒毒素注射内直肌是安全的,可作为先天性内斜视斜视手术的有价值替代方案,尤其适用于中度偏斜。

研究设计与样本

  • 系统评价与Meta分析,检索LILACS、MEDLINE和Cochrane CENTRAL数据库,检索时间为2016年12月28日至2017年1月30日,限定英文、西班牙文或葡萄牙文,无日期限制,共纳入9项研究。

主要发现

  • 肉毒毒素治疗婴儿性内斜视的合并成功率为76%(95%CI:61%-89%),异质性I²=94.25%(P<0.001)。
  • 合并连续性外斜视率为1%(95%CI:0%-2%),合并上睑下垂率为27%(95%CI:21%-33%),合并垂直偏斜率为12%(95%CI:4%-22%)。
  • 肉毒毒素注射后偏斜度平均变化为-30.7(95%CI:-37.7,-23.8),显示眼位显著改善。

临床怎么用

  • 作者认为肉毒毒素注射内直肌是安全的,可作为先天性内斜视斜视手术的有价值替代方案,尤其适用于中度偏斜。

局限性

  • 成功率分析的异质性I²=94.25%(P<0.001),提示高度异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this review was to examine the efficacy of botulinum toxin in the treatment of infantile esotropia and to evaluate the average response of BT and its complication rates. METHODS: A research was performed in the Latin American and Caribbean Literature on Health Sciences (LILACS), MEDLINE, and Cochrane Central Register of Controlled Trial (CENTRAL). The database was searched between December 28, 2016 and January 30, 2017. The selection was restricted to articles published in English, Spanish, or Portuguese. There were no date restrictions in the search. RESULTS: Nine studies were eligible for inclusion. The grouped success rate of BT treatment in infantile esotropia was 76% (95% confidence interval [CI]: 61%-89%). For the success rate, I2 of 94.25% was observed, indicating a high heterogeneity (P < 0.001). The complication rates were also analyzed. The grouped consecutive exotropia (XT) rate was 1% (95% CI: 0%-2%). The grouped ptosis rate was 27% (95% CI: 21%-33%). The grouped vertical deviation rate was 12% (95% CI: 4%-22%). The mean change of the deviation after BT injection was -30.7 (95% CI: -37.7, -23.8), demonstrating a significant improvement in alignment. CONCLUSIONS: Botulinum toxin injection into medial recti muscles reveals to be a safe procedure and a valuable alternative to strabismus surgery in congenital esotropia, especially in moderate deviations.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Issaho DC, Carvalho FRS, Tabuse MKU, et al. The Use of Botulinum Toxin to Treat Infantile Esotropia: A Systematic Review With Meta-Analysis. Invest Ophthalmol Vis Sci. 2017. PMID: 29059315. doi:10.1167/iovs.17-22576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。